 Spero Therapeutics, Inc. NASDAQ:SPRO Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants Ted Jenkins - Vice President-Investor Relations Strategic Finance Ankit Mahadevia - Chief Executive Officer David Melnick - Consultant Senior Clinical Advisor Sath Shukla - Chief Financial Officer Conference Call Participants Ritu Baral - Cowen Louise Chen - Cantor Boobalan Pachaiyappan - H.C. Wainwright Operator Good afternoon, and welcome to the Spero Therapeutics Second Quarter 2022 Financial Results Conference Call. 